微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -1.86% | -16.25% | 92.53% | 120/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -24.9% | -40.12% | -247.77% | 126/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | -7.16% | -137.09% | -68.87% | 125/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | -4.24% | -123.16% | -165% | 124/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | -1.6% | -128.57% | 91% | 121/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | -17.77% | -183.87% | -488.41% | 127/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | -3.02% | -602.33% | -58.95% | 115/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -1.9% | -1457.14% | -171.43% | 117/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.7% | -161.95% | 88.82% | 113/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | -6.26% | -128.53% | -1355.81% | 118/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | -0.43% | -101.75% | -407.14% | 111/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 0.14% | -88.24% | -87.61% | 110/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.13% | 91.53% | -94.85% | 80/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 21.94% | -7.7% | -10.67% | 20/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 24.56% | 17.4% | 1963.87% | 17/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 1.19% | -91.49% | 101.69% | 104/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 0.59% | -94.29% | -97.52% | 94/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 23.77% | -1.61% | 13.62% | 29/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 20.92% | 34.62% | 49.64% | 21/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 13.98% | 83.95% | 35.33% | 24/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 10.33% | 391.9% | -57.24% | 14/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | 24.16% | 198.64% | 55.47% | 37/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 15.54% | 69.28% | 104.47% | 36/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | 7.6% | 30.58% | 261.9% | 54/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 2.1% | -6.67% | -74.04% | 38/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | 8.09% | -4.03% | -11.87% | 87/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 9.18% | -4.47% | 57.73% | 34/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 5.82% | -9.77% | 158.67% | 36/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 2.25% | -6.25% | -73.31% | 30/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 8.43% | -21.36% | -12.28% | 75/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 9.61% | 0.42% | 48.99% | 24/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 6.45% | 2.54% | 168.75% | 21/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 2.4% | 2.13% | -77.61% | 24/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 10.72% | -12.42% | 12.02% | 62/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 9.57% | -16.78% | 52.15% | 23/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 6.29% | -13.84% | 167.66% | 28/139 | 5.88% | XD基蛋生 | 23.11% | 行业排名> |
| 2017-03-31 | 2.35% | -28.35% | -80.8% | 21/139 | 2.65% | XD基蛋生 | 11.34% | 行业排名> |
| 2016-12-31 | 12.24% | 1.24% | 6.43% | 48/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 11.5% | -9.73% | 57.53% | 11/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 7.3% | 3.25% | 122.56% | 16/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 3.28% | -16.75% | -72.87% | 9/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |